Lee Yoonha, Lee Young Ah, Ko Jung Min, Shin Choong Ho, Lee Yun Jeong
Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hwasung, Korea.
Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Ann Pediatr Endocrinol Metab. 2024 Dec;29(6):379-386. doi: 10.6065/apem.2448008.004. Epub 2024 Dec 31.
To investigate the clinical characteristics and genetic features of childhood-onset congenital combined pituitary hormone deficiency (cCPHD) in Korean patients.
We retrospectively analyzed 444 patients diagnosed with childhood-onset CPHD at a tertiary center between 1994 and 2021. After excluding acquired case, 43 patients with cCPHD were enrolled. Anthropometric measurements, hormone evaluations, brain magnetic resonance imaging (MRI), extrapituitary phenotypes, and adult outcomes were analyzed. Genetic analyses were performed on 26 patients using a targeted gene panel or whole exome sequencing.
Mean age at diagnosis was 3.2 years, and 41.9% were diagnosed at less than 1 year old. Short stature was the most frequent (37.2%) initial presentation, and mean height z-score was -2.4. More than half (n=23, 53.5%) of patients had neonatal features suggestive of hypopituitarism; however, only 15 (65.2%) were diagnosed in infancy. Growth hormone deficiency (GHD) was prevalent in 42 (97.7%), and 33 (76.7%) had 3 or more hormone deficiencies. Extrapituitary phenotypes were identified in 31 (72.1%). Brain MRI abnormalities correlated with a higher number of hormone deficiencies (P for trend 0.049) and were present in 33 patients (80.5%). Adult GHD was diagnosed in all 17 investigated patients, and metabolic disturbances were noted in 10 (58.9%). Pathogenic variants in POU1F1, GLI2, HESX1, TBC1D32, and ROBO1 were found in 5 (19.2%).
Considering the high proportion of neonatal presentations, identification of the early neonatal features of hypopituitarism to manage pituitary and extrapituitary phenotypes is critical. The genetic etiology of cCPHD warrants further exploration.
研究韩国儿童期起病的先天性联合垂体激素缺乏症(cCPHD)患者的临床特征和遗传特征。
我们回顾性分析了1994年至2021年间在一家三级中心诊断为儿童期起病的CPHD的444例患者。排除后天性病例后,纳入43例cCPHD患者。分析了人体测量、激素评估、脑磁共振成像(MRI)、垂体外表型和成人结局。对26例患者使用靶向基因panel或全外显子测序进行基因分析。
诊断时的平均年龄为3.2岁,41.9%在1岁前被诊断。身材矮小是最常见的(37.2%)初始表现,平均身高Z值为-2.4。超过一半(n = 23,53.5%)的患者有提示垂体功能减退的新生儿特征;然而,只有15例(65.2%)在婴儿期被诊断。生长激素缺乏症(GHD)在42例(97.7%)中普遍存在,33例(76.7%)有3种或更多激素缺乏。31例(72.1%)发现有垂体外表现型。脑MRI异常与更多的激素缺乏相关(趋势P值为0.049),33例患者(80.5%)存在脑MRI异常。所有17例接受调查的患者均被诊断为成人GHD,10例(58.9%)出现代谢紊乱。在5例(19.2%)中发现POU1F1、GLI2、HESX1、TBC1D32和ROBO1的致病变异。
考虑到新生儿表现的高比例,识别垂体功能减退的早期新生儿特征以管理垂体和垂体外表现型至关重要。cCPHD的遗传病因值得进一步探索。